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INTRODUCTION
Acute kidney injury (AKI) is one of the most intriguing 
challenges in medicine, as it is accompanied by high 
mortality rates despite the progress in understanding 
and treating the condition. AKI is dei ned as a rapid 
and varied loss of kidney function which results in a 
wide spectrum of injuries, ranging from mild to severe 
(1). Resulting kidney dysfunction leads to the accumu-
lation of waste products as well as a volume and elec-
trolyte disbalance which causes systemic damage (2). 
AKI is usually clinically diagnosed by RIFLE classii -
cation, given by ADQI group, and AKIN classii cation, 
given by AKIN group (3). Elderly patients form a par-
ticularly sensitive group, due to lower renal reserves 
and complications which come with age and various 
comorbid conditions such as hypertension, diabetes, 
atherosclerosis and heart failure (4). Continuous renal 
replacement therapy (CRRT) is a variety of extracor-
poreal blood purii cation technique used to substitute 
impaired renal function for a prolonged period (5). 
Despite the advance in CRRT, it is still characterized 
by high mortality, especially in elderly patients with 
AKI (6). It bears some risks, including access-related 
complications, extracorporeal circuit-associated com-
plications, hemodynamic compromise, electrolyte and 
metabolic complications together with human factors 
(7). h ere is no consensus regarding the right time to 
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initiate CRRT and it remains an important question 
for the treatment (8). h e aim of the study was to ana-
lyze the state of patients treated with CRRT, specii cal-
ly regarding mortality and loss or recovery of kidney 
functions, along with parameters which could af ect 
the outcome and which could be improved during 
therapy for better results.
AIM OF THE RESEARCH
Acute kidney injury is associated with excess mortality 
rates and information for elderly patients are limited. 
h erefore, the primary goal of this retrospective study 
was to determine the mortality of the elderly patients 
with AKI who underwent CRRT. Comorbidities, etiol-
ogy and parameters were also observed as a potential 
predictor of mortality. 
METHODS
Patient selection
A retrospective study was conducted in Clinical Hos-
pital Center Rijeka on the elderly patients (≥ 65 years) 
with AKI. 178 patients were admitted to the intensive 
care unit between January 1st 2010 and December 31st 
2015, including 64 female and 114 male patients. h e 
average age was 74,35 ± 5,46 (65 to 89 years). All par-
ticipants of the study were treated with continuous re-
nal replacement therapy, which include 147 patients 
with CVVHD, 20 patients with CVVHDF, 8 patients 
with CVVH and 3 patients with CVVHDF + OXIRIS. 
h e average time on CRRT was 58.95 ± 53.01 (2-259) 
hours. h is retrospective study was approved by Ethics 
Committee of Clinical Hospital Center Rijeka and it 
was conducted according to the principles of the Dec-
laration of Helsinki.
Inclusion criteria
According to the Kidney Disease Improving Global 
Outcomes (KIDIGO) criteria, AKI is dei ned as any 
of the following: increase in SCr by ≥ 26.5 μmol/l (≥ 
0.3 mg/dl) within 48 hours; or increase in Scr to ≥ 1.5 
times baseline in prior 7 days; or urine volume < 0.5 
ml/kg/h for 6 hours (9). Patients with chronic kidney 
disease (CKD) stage 4 and 5, kidney transplantation 
and patients younger then 65 years were excluded 
from the study. 
Limitations
Limitations in interpreting the results mostly stem 
from the fact that the three outcome groups of patients 
and dif erent in number, especially the dialysis out-
come group with a small sample size. Furthermore, fu-
ture studies should objectivize patient state using stan-
dard scoring used in intensive medicine (APACHE II, 
SPAS II, SOFA) to improve the possible analysis.
Data collection
h e data was collected from the Integral hospital in-
formation system. h e following indicators were re-
corded: general information, such as age, sex, prima-
ry disease, complications; vital signs, such as blood 
pressure, urine output, temperature, oxygenation; 
laboratory parameter such as kid ney function, blood 
routine, electrolytes. Patients were divided into three 
groups and then compared according to the out-
come and their baseline characteristics. Groups were 
non-survival group (n=126), renal recovery group 
(n=42) and dialysis group (n=11). Mortality was cal-
culated according to the statistical survival time of pa-
tients 4 weeks at er CRRT, with renal recovery being 
based on creatinine clearance (30 ml per hour urine 
l ow increase or spontaneous serum creatinine fall). 
Statistical analysis
Statistical analysis was performed using descriptive 
statistics, expressed as the mean ± standard deviation 
of minimal and maximum value. One-way ANOVA 
was used for normally distributed samples, which were 
additionally verii ed using the Kruskal-Wallis test due 
to the low sample count in one of the groups. Krus-
kal-Wallis test was also used for comparing the non-
parametric samples of independent groups. P value 
of <0.05 has been considered statistically signii cant. 
Statistical analysis was performed using the MedCalc 
10 sot ware (MedCalc, Mariakerke, Belgium).
RESULTS
Total number of analyzed patients was 178, consisting 
of 114 male (64.04%) and 64 female (35.96%) patients, 
mean age 74.35 ± 5.46 (65-89), who were treated with 
continuous renal replacement therapy due to AKI. h e 
most common indication for CRRT was of cardiac 
(n=89) and infective etiology (n= 52). h e mean time of 
CRRT in patients was 58.95 ± 53.01 hours. h e mortal-
ity rate was 70.79% (126 patients), 23.03% (41 patients) 
recovered renal function with no need for further re-
nal replacement therapy, while 6.18% (11 patients) re-
quired renal replacement therapy. h ere were no statis-
tical signii cant dif erences among groups in the gender 
(p=0.677) and the mean age (p=0.634)(Table 1).
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Table 1. 
Characteristics of patients treated with CRRT. 
Demographics
Total patients 178
Age (y) 74.35 ± 5.46 (65-89)
Sex (M/F) 114 (64.04%) / 64 (35.96%)
Causes of AKI/
CRRT indication 
(%)
Ischemia 76 (42.70%)
Sepsis/Infection 62 (34.83%)
Surgery 40 (22.47%)
Comorbidities (%)
Diabetes 59 (33.15%)
Hypertension 124 (69.66%)
Cardiopathies 145 (81.46%)
Outcome (%)
Death (non-survival) 126 (70.79%)
Dialysis 11 (6.18%)
Renal function recovery 41 (23.03%)
Initial levels of serum creatinine were statistical-
ly higher in the dialysis outcome group (649.81 ± 
332.89) compared to the renal recovery group (341.05 
± 164.05) and non-survival group (420.07 ± 200.78), 
which had no mutually signii cant dif erence (Figure 
1A). Creatinine levels at the end of CRRT were highest 
in the dialysis group (407.00 ± 227.92) and non-sur-
vival group (294.06 ± 158.82), which were both statis-
tically higher than the renal recovery group (185.82 ± 
108.6). However, there was no statistically signii cant 
dif erences between the two former groups in end 
creatinine levels (Figure 1B). Furthermore, measured 
24-hour diuresis was only signii cantly higher in the 
renal recovery group (782.33 ± 675.05) compared to 
the non-survival group (541.76 ± 863.73) (Figure 1C). 
Interestingly, initial glomerular i ltration rates were 
rather dif erent between all three groups. h e renal 
recovery group had signii cantly higher GFR (19.25 
± 9.94) compared to both groups, while the dialysis 
group had the lowest GFR of the three groups (8.00 
± 5.47) (Figure 1D). Measuring initial potassium re-
vealed a mild, statistically signii cant, hyperkalemia in 
the non-survival group (5.30 ± 1.06) compared to the 
renal recovery group (4.77 ± 0.83). h e renal recov-
ery and the dialysis groups (5.01 ± 0.84) had normal 
potassium levels, although the latter had borderline 
levels (Figure 1E). Finally, the analysis of multiple or-
gan dysfunction revealed a greatly increased incidence 
in the non-survival group (n=57. 45%) compared to 
the renal recovery group (n=9. 23%) and the dialysis 
group (n=2. 18%) (Figure 1F).
Fig. 1. Results of the kidney function, postassium and MODS.
Initial levels of serum creatinine were statistically higher in the dialysis outcome group (649.81 ± 332.89) compared to the renal recovery group 
(341.05 ± 164.05) and non-survival group (420.07 ± 200.78), which had no mutually signii cant dif erence (Figure 1A). Creatinine levels at the end 
of CRRT were highest in the dialysis group (407.00 ± 227.92) and non-survival group (294.06 ± 158.82), which were both statistically higher than 
the renal recovery group (185.82 ± 108.6). However, there was no statistically signii cant dif erences between the two former groups in end creatinine 
levels (Figure 1B). Furthermore, measured 24-hour diuresis was only signii cantly higher in the renal recovery group (782.33 ± 675.05) compared to 
the non-survival group (541.76 ± 863.73) (Figure 1C). Interestingly, initial glomerular i ltration rates were rather dif erent between all three groups. 
h e renal recovery group had signii cantly higher GFR (19.25 ± 9.94) compared to both groups, while the dialysis group had the lowest GFR of the 
three groups (8.00 ± 5.47) (Figure 1D). Measuring initial potassium revealed a mild, statistically signii cant, hyperkalemia in the non-survival group 
(5.30 ± 1.06) compared to the renal recovery group (4.77 ± 0.83). h e renal recovery and the dialysis groups (5.01 ± 0.84) had normal potassium 
levels, although the latter had borderline levels (Figure 1E). Finally, the analysis of multiple organ dysfunction revealed a greatly increased incidence 
in the non-survival group (n=57. 45%) compared to the renal recovery group (n=9. 23%) and the dialysis group (n=2. 18%) (Figure 1F).
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DISCUSSION
In 1977 the continuous arteriovenous hemoi ltration, 
which was the predecessor od today’s CVVHDF, was 
described by Kramer for the i rst time. (10). Although 
further improvement of the continuous replacement 
therapy contributed to greater survival rates, mortal-
ity is still high. Particularly sensitive and vulnerable 
group are elderly patients (≥65 years). Due to their 
physiological aging, anatomic and structural chang-
es in the kidney lead to the functional deterioration, 
which presents itself as a decrease in glomerular i l-
tration rate and renal blood l ow (11). Age-related 
changes occur in every organ system and they vary 
from one individual to another (12). A mixture of ag-
ing, complications and various comorbidities lead to a 
condition susceptible for diseases.
Acute kidney injury is related to the high mortality 
rate, which amount from 40% to 70% in general pop-
ulation (13). Metnitz et al. performed a prospective, 
multicenter study in Austria to explore the association 
between AKI and the mortality rate. h e prevalence of 
patients with AKI, who underwent CRRT, was 4,9% 
in the intensive care unit. h eir mortality rate was 
62.8% with mean age 65.2 ± 15.2 years (14). Uchino 
et al. conducted a prospective, multicenter and mul-
tinational study about AKI in critically ill patients in 
intensive care unit. h e mean age of observed patients 
was 67 years (53-75 years) and the overall mortality 
rate was 60,3%.One of the goals was to determine the 
prevalence of AKI requiring RRT and it was from 5% 
to 6% (15). Liu et al. have reported 60,98% mortality 
rate for elderly patients, mean age 88,65 ± 4,76 years 
(16), while Gong et al. have reported 42% mortality 
rate with mean age 77.89 ± 7.86 years (4). In this study, 
despite the younger average age (74.35 ± 5.46 years), 
the analyzed patients had a higher mortality rate 
(70.79%). h e Eurostat statistical information shows 
that the European population is aging and the life ex-
pectancy is increasing. h e percentage of elderly peo-
ple in 2015 in France was 18,4%, in Austria and Spain 
18.5%, in Croatia 18.8, in Germany 21.0% and in Italy 
21.7% (17). h erefore, studying diseases and dif er-
ences in connection with age is needed and relevant.
Furthermore, no dif erence was found in gender and 
age among analyzed groups, which is in accordance 
with the studies performed by Gong et al. and Liu et al. 
(4)(16). As in this study, Yokota et al. also did not i nd 
any correlation between concomitant diseases, like hy-
pertension, diabetes mellitus, and cardiovascular dis-
eases, and an excess risk of death (18). Interestingly, 
Gong et al. reveal that concomitant diseases present 
in elderly patients with AKI are an independent risk 
factor for death and the most frequent ones are car-
diovascular diseases, diabetes, sepsis and hyperten-
sion. h e main causes of AKI in this study with elderly 
patients, who underwent CRRT, were ischemia (n=76, 
42.70%), sepsis/infection (n=62, 34.83%) and sur-
gery (n=40, 22.47%), while Gong et al. had a smaller 
number of sepsis (n=10, 10.10%), but more ischemic 
causes (n=53. 54%), then surgery (n=33, 33.33%) and 
nephrotoxic drug (n=3, 3.03%)(4).
Creatinine levels measured initially and creatinine 
levels measured at the end of CRRT were the highest 
in the dialysis group, compared to the other groups, 
which had no mutually signii cant dif erences. High 
serum creatinine in the dialysis group was elucidated 
with etiology of AKI, which is chronic kidney disease, 
stage 1 to 3 (stages 4 and 5 were excluded). However, 
the dif erence among the non-survival and the renal 
recovery group is consistent with results from Liu et al, 
who completely excluded patients with chronic kidney 
disease (stage 1 to 5) (16). Furthermore, a signii cantly 
higher urine output measured over a 24-hour period 
was present only in the renal recovery group, com-
pared to the non-survival group, which tells us that 
24-hour diuresis can be one of the predictors of out-
come in AKI. Beside diuresis, glomerular i ltration rate 
provides information about kidney function. Initial 
glomerular i ltration rates were signii cantly dif erent 
between analyzed groups. h e renal recovery group 
had the highest GFR among all three groups, while the 
dialysis group had the lowest GFR, due to the chronic 
kidney disease (stage 1 to 3) in the background. h ere-
fore, initial GFR can be one of the predictors of out-
come. Interestingly, statistically signii cant dif erence 
in initial potassium was noticed between non-survival 
and renal recovery group, but not between non-sur-
vival and dialysis group. However, Gong et al. have 
reported normal potassium levels in the non-survival 
group (4.0 mmol/L, 3.7-4.9), as well as in the survival 
group (4.2 mmol/L, 3.7-4.7) (4), which is more pref-
erable, because inadequate potassium regulation can 
precipitate or result in life-threatening condition (19). 
According Gong et al., MODS was independent risk 
factor in the death of patients with AKI. h e mean 
mortality rate for elderly patients was 42% and it was 
increasing with the number of failed organs. With the 
dysfunction of 2 organs, the mortality rate was 39%, 3 
organs was 50%, 4 organs was 60% and 100% for the 
dysfunction of 5 organs (4). In this study the non-sur-
vival group had higher incidence of MODS (45%) 
compared to the renal recovery group (23%) and the 
dialysis group (18%). h erefore, MODS is one of the 
predictors of mortality. Liu et al. also reported that 
MODS increased incidence of mortality (16). Yokota 
et al. found that elderly patients with septic complica-
tions are prone to develop MODS, which increases the 
risk of mortality (18).h e results summary between 
the three analyzed groups were shown in Table 2.
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Table 2.
Results summary between the three groups.
NON-SURVIVAL (N=126) RENAL RECOVERY (N=41) DIALYSIS (N=11) P
Age (y) 74,45 ± 5,54 74,29 ± 5,42 72,81 ± 4,91 0,634
Sex (% M) 82 (65) 24 (58) 6 (54) 0,677
24-hour diuresis (mL) 541,76 ± 863,73 782,33 ± 675,05 357,00 ± 389,35 <0,05
Initial creatinine (µmol/L) 420,07 ± 200,78 341,05 ± 164,05 649,81 ± 332,89 <0,05
Endpoint creatinine (µmol/L) 294,06 ± 158,82 185,82 ± 108,6 407,00 ± 227,92 <0,05
Initial potassium(mmol/L) 5,30 ± 1,06 4,77 ± 0,83 5,01 ± 0,84 <0,05
Initial urea (mmol/L) 26,05 ± 12,63 22,39 ± 11,48 26,34 ± 12,76 0,262
GFR (ml/min/1.73 m2) 14,21 ± 8,65 19,25 ± 9,94 8,00 ± 5,47 <0,05
MODS [(n)%] 57 (45) 9 (23) 2 (18) <0,05
Surgical procedure [(n)%] 67 (53) 25 (61) 4 (45) 0,565
Abbreviations: CRRT – continuous renal replacement therapy; GFR – glomerular i ltration rate; MODS – multiple organ dys-
function syndrom; 
CONCLUSIONS
h is study found out that the mortality rate of elderly 
patients with AKI, who underwent CRRT, was 70,79%, 
and that 24-hour diuresis, GFR and MODS were inde-
pendent risk factors for the death.
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Akutna bubrežna ozljeda je jedan od intrigantnijih problema medicine, budući da je i dalje prati visok mortalitet unatoč 
napretku u liječenju i razumijevanju same bolest. Posebno osjetljivu skupinu čine stariji pacijenti, koji su zbog same dobi i 
svih komorbiditeta posebno ugroženi. Cilj studije bio je analizirati ishod pacijenata na CRRT-u, odnosno mortalitet, gubitak 
i oporavak bubrežne funkcije, kao i parametre koji bi potencijalno mogli upućivati na mogući ishod, no na koje bi se ujedno 
moglo i utjecati u svrhu boljeg preživljenja.
U ispitivanju su sudjelovali pacijenti oboljeli od ABO liječeni u Kliničkom bolničkom centru Rijeka u razdoblju od 5 g. Ukupan 
broj ispitanika bio je 178, od toga 64 osoba ženskog i 114 osobe muškog spola. Prosječna dob iznosila je 74,35 ± 5,46 (65-
89) godina. Svi analizirani pacijenti su se liječili kontinuiranim nadomještanjem bubrežne funkcije. Pacijenti su raspoređeni 
u tri skupine ovisno o ishodu bolesti, odnosno smrt, gubitak i oporavak bubrežne funkcije. Najčešće indikacije za primjenu 
kontinuiranog nadomještanja bubrežne funkcije bile su kardiogene etiologije (n=89, 50,0 %) te infektivne etiologije (n=52, 
29,2 %). Mortalitet pacijenata oboljelih od ABO koji su bili na kontinuiranom nadomještanju bubrežne funkcije iznosi 70,79 
% (n=126), dok se renalna funkcija oporavila u 6,18 % pacijenata (n=11), a 23,03 % pacijenata je moralo nastaviti jednom 
od metoda nadomještanja bubrežne funkcije (n=41). Analizom podataka dobiveno je da vrijednosti inicijalno mjerenog 
kreatinina, 24-satne diureze, glomerularne ﬁ ltracije, kalija, kao i višestruko zatajenje organa, mogu biti jedan od prediktora 
ishoda ABO u starijih pacijenata. 
Ključne riječi: kontinuirano nadomještanje bubrežne funkcije, akutna bubrežna ozljeda, stariji, mortalitet
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